Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F I Preffer

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Journal of Immunological Methods|October 31, 2015
A novel approach to measuring cell-mediated lympholysis using quantitative flow and imaging cytometryG M La Muraglia, M J O'Neil, M L Madariaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MISP T Masiakos, D T MacLaughlin, S Maheswaran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxelR. T. Penson, K. Kronish, Z. Duan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allograftsA B Farris, D Taheri, T Kawai, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 3, 2017
Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney-Bone Marrow Transplantation to Induce Transplantation ToleranceB Sprangers, S DeWolf, T M Savage, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Journal of Immunological Methods|October 31, 2015
A novel approach to measuring cell-mediated lympholysis using quantitative flow and imaging cytometryG M La Muraglia, M J O'Neil, M L Madariaga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MISP T Masiakos, D T MacLaughlin, S Maheswaran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxelR. T. Penson, K. Kronish, Z. Duan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allograftsA B Farris, D Taheri, T Kawai, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 3, 2017
Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney-Bone Marrow Transplantation to Induce Transplantation ToleranceB Sprangers, S DeWolf, T M Savage, et al.
Pageof 6